Physician profile
John F Valente
NPI 1134192412
$2,647.04
in general payments reported to CMS, 2019-2025
33 companies · $366 in 2025
The $366 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $484 · 2020: $108 · 2021: $307 · 2022: $934 · 2023: $170 · 2024: $278 · 2025: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.32 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $114.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $629.08 | 2019-2022 | |
| Endologix LLC | $371.01 | 2020-2024 | Alto Abdominal Stent Graft System |
| Ethicon US, LLC | $256.66 | 2019-2024 | Surgiflo Hemostatic Matrix, Dermabond Prineo, Mega Soft |
| Bard Peripheral Vascular, INC. | $188.16 | 2019-2022 | |
| Abbvie INC. | $135.13 | 2024-2025 | |
| Integra Lifesciences Corporation | $115.57 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Boston Scientific Corporation | $104.00 | 2025 | Wavewriter Alpha Prime 16 |
| Allergan, INC. | $102.01 | 2019-2022 | |
| Davol INC. | $101.45 | 2019-2021 | |
| Mozarc Medical US LLC | $59.94 | 2023 | Chameleon |
| Medtronic, INC. | $52.35 | 2022-2024 | Ligasure, Chameleon |
| Tela Bio, INC. | $45.16 | 2020-2021 | |
| Conmed Corporation | $42.78 | 2019 | |
| Scilex Pharmaceuticals INC. | $41.51 | 2025 | |
| Sanara Medtech INC. | $41.42 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $37.70 | 2025 | Xtampza |
| Covidien LP | $30.21 | 2019 | |
| Tei Biosciences INC | $25.82 | 2019 | |
| Protega Pharmaceutials INC | $25.23 | 2025 | Roxybond |
| Kerecis Limited | $24.60 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Silk Road Medical, INC. | $24.17 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Indivior INC. | $21.23 | 2025 | Sublocade |
| Janssen Pharmaceuticals, INC | $19.86 | 2022 | |
| Getinge USA Sales, LLC | $18.49 | 2021 | |
| Depuy Synthes Sales INC. | $17.74 | 2022 | |
| Paratek Pharmaceuticals, INC. | $17.44 | 2021 | |
| Abbott Laboratories | $17.37 | 2025 | Proclaim |
| Mallinckrodt Enterprises LLC | $16.31 | 2019 | |
| Terumo Medical Corporation | $15.08 | 2019 | |
| Averitas Pharma INC. | $14.59 | 2025 | Qutenza |
| Cumberland Pharmaceuticals, INC. | $12.95 | 2019 | |
| Medtronic Vascular, INC. | $12.02 | 2020 | |
| Intra-Sana Laboratories | $10.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Valente listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.